|
EP3694887A1
|
|
Monoclonal antibodies and conjugates against prostaglandin f2 receptor inhibitor and uses thereof
|
|
EP2467160A2
|
|
Materials and methods for the development of an antigen-specific immune non-responsiveness state
|
|
CN107085108A
|
|
The method for diagnosing cancer and determining the overall survival and disease-free survival of cancer patient
|
|
US2010111928A1
|
|
Methods and kits for diagnosis tumorgenicity
|
|
AU2007229401A1
|
|
Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic efffects of antiestrogen therapy
|
|
WO2005000240A2
|
|
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
|
|
EP1849480A2
|
|
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
|
|
WO2004094612A2
|
|
Cancer specific monoclonal antibodies
|
|
US2004265930A1
|
|
Monoclonal antibody 7H11 reactive with human cancer
|
|
US7411045B2
|
|
Autocrine growth factor receptor antibodies and methods
|
|
US7091047B2
|
|
Methods and kits for diagnosing tumorigenicity
|
|
US6881548B2
|
|
Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
|
|
US6720159B1
|
|
88KDA tumorigenic growth factor and antagonists
|
